SLC5A2 and sarcopenia: The study proposed the importance of intramuscular fatty acid metabolism and gene expression influenced by the extracellular lipidome modified by SGLT2 inhibitors as a mechanism for SGLT2 inhibitors alleviating sarcopenia [17].